The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
A Meta-Analysis of 16 Randomized Trials of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease
Open accessAbstract
OBJECTIVES Our purpose was to make a synthesis of the available evidence on the relative efficacy and safety of 2 drug-eluting stents (DES)--sirolimus-eluting stent (SES) and paclitaxel-eluting stent (PES)--in patients with coronary artery disease. BACKGROUND It is not known whether there are differences in late outcomes between the 2 most commonly used DES: SES and PES. METHODS Sixteen randomized trials of SES versus PES with a total number of 8,695 patients were included in this meta-analysis. A full set of individual outcome data from 5,562 patients was also available. Mean follow-up period ranged from 9 to 37 months. The primary efficacy end point was the need for reintervention (target lesion revascularization). The primary safety end point was stent thrombosis. Secondary end points were death and recurrent myocardial infarction (MI). RESULTS No significant heterogeneity was found across trials. Compared with PES, SES significantly reduced the risk of reintervention (hazard ratio [HR] 0.74; 95% confidence interval [CI] 0.63 to 0.87, p < 0.001) and stent thrombosis (HR 0.66; 95% CI 0.46 to 0.94, p = 0.02) without significantly impacting on the risk of death (HR 0.92; 95% CI 0.74 to 1.13, p = 0.43) or MI (HR 0.84; 95% CI 0.69 to 1.03, p = 0.10). CONCLUSIONS Sirolimus-eluting stents are superior to PES in terms of a significant reduction of the risk of reintervention and stent thrombosis. The risk of death was not significantly different between the 2 DES, but there was a trend toward a higher risk of MI with PES, especially after the first year from the procedure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Assessing the quality of controlled clinical trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · BMJ · doi:10.1136/bmj.323.7303.42 · Cited by 3,309
Self-citationPathology of Drug-Eluting Stents in Humans
Joner, M., Finn, A. V., Farb, A., Mont, E. K., Kolodgie, F. D., Ladich, E., Kutys, R., Skorija, K., Gold, H. K., & Virmani, R. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.042 · Cited by 2,744
Systematic Reviews in Health Care : Meta-Analysis in Context
Egger, M., Smith, G. D., & Altman, D. G. (2000) · Cited by 2,401
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
Jüni, P. (1999) · JAMA · doi:10.1001/jama.282.11.1054 · Cited by 1,981
Self-citationDaemen, J., Wenaweser, P., Tsuchida, K., Abrecht, L., Vaina, S., Morger, C., Kukreja, N., Jüni, P., Sianos, G., Hellige, G., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60314-6 · Cited by 1,757
Self-citationSystematic Reviews in Health Care: Meta‐Analysis in Context
(2001) · doi:10.1002/9780470693926 · Cited by 1,693
Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy
McFadden, E. P., Stabile, E., Regar, E., Cheneau, E., Ong, A. T., Kinnaird, T., Suddath, W. O., Weissman, N. J., Torguson, R., Kent, K. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17275-9 · Cited by 1,436
Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents
Pfisterer, M., Brunner-La Rocca, H. P., Buser, P. T., Rickenbacher, P., Hunziker, P., Mueller, C., Jeger, R., Bader, F., Osswald, S., & Kaiser, C. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.026 · Cited by 1,303
Self-citationGrines, C. L., Bonow, R. O., Casey, D. E., Gardner, T. J., Lockhart, P. B., Moliterno, D. J., O’Gara, P., & Whitlow, P. (2007) · Circulation · doi:10.1161/circulationaha.106.180944 · Cited by 1,140
Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal Stents
Kastrati, A., Mehilli, J., Pache, J., Kaiser, C., Valgimigli, M., Kelbæk, H., Menichelli, M., Sabaté, M., Suttorp, M. J., Baumgart, D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067484 · Cited by 1,006
Self-citationA hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents
Babapulle, M. N., Joseph, L., Bélisle, P., Brophy, J. M., & Eisenberg, M. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16850-5 · Cited by 645
Kastrati, A., Mehilli, J., von Beckerath, N., Dibra, A., Hausleiter, J., Pache, J., Schühlen, H., Schmitt, C., Dirschinger, J., Schömig, A., et al. (2005) · JAMA · doi:10.1001/jama.293.2.165 · Cited by 605
Self-citationSirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary Revascularization
Windecker, S., Remondino, A., Eberli, F. R., Jüni, P., Räber, L., Wenaweser, P., Togni, M., Billinger, M., Tüller, D., Seiler, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051175 · Cited by 593
Self-citationFinn, A. V., Kolodgie, F. D., Harnek, J., Guerrero, L. J., Acampado, E., Tefera, K., Skorija, K., Weber, D. K., Gold, H. K., & Virmani, R. (2005) · Circulation · doi:10.1161/circulationaha.104.508937 · Cited by 556
Simmonds, M. C., Higginsa, J. P. T., Stewartb, L. A., Tierneyb, J. F., Clarke, M. J., & Thompson, S. G. (2005) · Clinical Trials · doi:10.1191/1740774505cn087oa · Cited by 555
Moreno, R., Fernández, C., Hernández, R., Alfonso, F., Angiolillo, D. J., Sabaté, M., Escaned, J., Bañuelos, C., Fernández-Ortiz, A., & Macaya, C. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.065 · Cited by 544
Invited commentary: a critical look at some popular meta-analytic methods
Greenland, S. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117248 · Cited by 511
Late Thrombosis of Drug-Eluting Stents: A Meta-Analysis of Randomized Clinical Trials
Bavry, A. A., Kumbhani, D. J., Helton, T. J., Borek, P. P., Mood, G. R., & Bhatt, D. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.023 · Cited by 490
Nordmann, A. J., Briel, M., & Bucher, H. C. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl282 · Cited by 480
Morice, M.-C., Colombo, A., Meier, B., Serruys, P., Tamburino, C., Guagliumi, G., Sousa, E., Stoll, H.-P., & REALITY Trial Investigators, F. T. (2006) · JAMA · doi:10.1001/jama.295.8.895 · Cited by 458
Self-citationGrines, C. L., Bonow, R. O., Casey, D. E., Gardner, T. J., Lockhart, P. B., Moliterno, D. J., O'Gara, P., & Whitlow, P. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.003 · Cited by 404
Kaiser, C., Brunner-La Rocca, H. P., Buser, P. T., Bonetti, P. O., Osswald, S., Linka, A., Bernheim, A., Zutter, A., Zellweger, M., Grize, L., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67221-2 · Cited by 342
Self-citationSterne, J. A. C., Bradburn, M. J., & Egger, M. (2001) · Systematic Reviews in Health Care · doi:10.1002/9780470693926.ch18 · Cited by 297
Kastrati, A., Dibra, A., Eberle, S., Mehilli, J., Suárez de Lezo, J., Goy, J.-J., Ulm, K., & Schömig, A. (2005) · JAMA · doi:10.1001/jama.294.7.819 · Cited by 282
Self-citationSystematic Reviews in Health Care
Loo, L. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-7-200210010-00035 · Cited by 254
Kastrati, A., Dibra, A., & Eberle, S. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.10.047 · Cited by 235
Self-citationEgger, M., Ebrahim, S., & Smith, G. D. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.1 · Cited by 160
Trading Restenosis for Thrombosis? New Questions about Drug-Eluting Stents
Shuchman, M. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068234 · Cited by 134
Eisenberg, M. J., & Konnyu, K. J. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.02.042 · Cited by 93
Cited by
2013 ESC guidelines on the management of stable coronary artery disease
Task Force Members, Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht296 · Cited by 4,510
Self-citationPercutaneous Coronary Intervention of Functionally Nonsignificant Stenosis
Pijls, N. H. J., van Schaardenburgh, P., Manoharan, G., Boersma, E., Bech, J.-W., van’t Veer, M., Bär, F., Hoorntje, J., Koolen, J., Wijns, W., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.087 · Cited by 1,516
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis
Stettler, C., Wandel, S., Allemann, S., Kastrati, A., Morice, M. C., Schömig, A., Pfisterer, M. E., Stone, G. W., Leon, M. B., de Lezo, J. S., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61444-5 · Cited by 1,428
Self-citationRandomized Trial of Stents versus Bypass Surgery for Left Main Coronary Artery Disease
Park, S.-J., Kim, Y.-H., Park, D.-W., Yun, S.-C., Ahn, J.-M., Song, H. G., Lee, J.-Y., Kim, W.-J., Kang, S.-J., Lee, S.-W., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100452 · Cited by 680
Self-citationWindecker, S., Serruys, P. W., Wandel, S., Buszman, P., Trznadel, S., Linke, A., Lenk, K., Ischinger, T., Klauss, V., Eberli, F., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61244-1 · Cited by 653
Self-citation
Metadata
- Authors
- Schömig, A., Dibra, A., Windecker, S., Mehilli, J., Suárez de Lezo, J., Kaiser, C., Park, S.-J., Goy, J.-J., Lee, J.-H., Di Lorenzo, E., Wu, J., Jüni, P., Pfisterer, M. E., Meier, B., & Kastrati, A.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2007-10
- Volume
- 50
- Issue
- 14
- Pages
- 1373-1380
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2060153501
- Cited by
- 359
- References
- 32
- FWCI
- 6.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.